Prestige Consumer Healthcare Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 29.21%

Prestige Consumer Healthcare Inc. EBIT Margin is 29.21% for the Trailing 12 Months (TTM) ending March 31, 2025, a -4.19% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Prestige Consumer Healthcare Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 30.49%, a -1,078.28% change year over year.
  • Prestige Consumer Healthcare Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -3.12%, a -111.02% change year over year.
  • Prestige Consumer Healthcare Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 28.28%, a -5.07% change year over year.
  • Prestige Consumer Healthcare Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 29.79%, a 0.06% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin